Roseville, United States
Advanced Circulatory, founded in 1997, stands at the forefront of healthcare innovation with its unique offering: Intrathoracic Pressure Regulation (IPR) therapy. This non-invasive platform delivers "Perfusion On Demand," crucial for enhancing circulation and protecting vital organs like the heart and brain during medical emergencies.
The company specializes in impedance threshold devices (ITDs), such as the ResQPOD® and ResQGARD®, designed for both hospital and non-hospital cardiac care. These devices optimize circulation either during CPR or in spontaneously breathing patients with poor perfusion, respectively. The broader indication of these devices is their temporary use to boost blood circulation across various care settings in the United States.
While Advanced Circulatory has not yet received its latest round of investment, its ongoing research aims to further verify the long-term benefits of IPR therapy. Positioned within the Hardware, Health Care, Manufacturing, and Medical Devices industries, the company holds promising potential for strategic investors keen on pioneering medical technologies.
